Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-20

Clinical Trial Update: Acthar Gel for Active Systemic Lupus Erythematosus (SLE) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Acthar Gel in active systemic lupus erythematosus (SLE) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Lupus Erythematosus, Systemic | Phase 4 | Status: COMPLETED | Results posted: 2020-08-20